New balloon aims to clear calcified leg arteries safely

NCT ID NCT07397390

ENROLLING_BY_INVITATION Disease control Sponsor: The First Affiliated Hospital of Dalian Medical University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a special balloon designed to open up hardened leg arteries in people with peripheral artery disease. About 58 participants with moderate to severe calcium buildup will receive the balloon treatment. Researchers will check if the balloon successfully widens the artery and improves blood flow, and will follow patients for 6 months to see if further procedures are needed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DKutting LL scoring balloon (a medical device used to widen narrowed arteries)
What this could lead to: If successful, this balloon could offer a safer, more effective way to prepare hardened leg arteries for treatment, potentially reducing complications and repeat procedures.
What could go wrong: This is a small, early-stage study with only 58 participants and no comparison group. The balloon may not work better than standard treatments, and risks like artery damage or blockage remain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANGIOPLASTY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

calcinosis peripheral arterial disease Vascular Calcification

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANGIOPLASTY CALCIFICATIONS VASCULAR CUTTING BALLOON ANGIOPLASTY FEMORAL ARTERY STENOSIS INFRAPOPLITEAL ARTERIAL OCCLUSIVE DISEASE INTRAVASCULAR IMAGING DEVICE PERIPHERAL ARTERY DISEASE

Contacts and locations

Locations

The First Affiliated Hospital of Dalian Medical University

Dalian, Liaoning, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.